Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Medelis

Medelis
2003 FOUNDED
M&A STATUS
51-60 EMPLOYEES
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of clinical research services. The company provides research in the field of oncology-focused on pre-clinical and phase 1 through phase 4 oncology trials, along with drug development and consultancy services.

Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Parent Company
Primary Office
  • 30 Burton Hills Boulevard
  • Suite 500
  • Nashville, TN 37215
  • United States

+1 (615) 000-0000

Medelis Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Medelis‘s full profile, request access.

Request full access to PitchBook

Medelis Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Trial Runners Corporation Dickinson, ND 00
00000000000 Private Equity-Backed Exton, PA 00 000 000000000000 000
0000000000 Corporation Irvine, CA 00
0000 Corporation Dublin, Ireland 00000 00000 000000000 00000
000000 0000000000 Formerly PE-Backed Edinburgh, United Kingdom 000000000000
To view this company’s complete list of competitors, request access »

Medelis Executive Team (2)

Name Title Board
Seat
Contact
Info
Dan Weng MD President & Chief Executive Officer

1 Former Executive

You’re viewing 1 of 2 executives. Get the full list »